1) Testicular carcinoma-in-situ
睾丸原位癌
2) Cancer-testis antigen
癌-睾丸抗原
1.
Prediction of HLA-A2/A3-restricted broad spectrum CTL epitope derived from the cancer-testis antigen SSX-3;
癌-睾丸抗原SSX-3的HLA-A2/A3限制性CTL广谱表位的预测
2.
Objective: To investigate the expression of Cancer-Testis Antigen SCP-1 mRNA in human nasopharyngeal carcinoma, and explore the potential possibility in the immunodiagnosis and immunotherapy of nasopharyngeal carcinoma with SCP-1.
目的:了解癌-睾丸抗原SCP-1 mRNA在人鼻咽癌的表达情况,探讨SCP-1用于鼻咽癌免疫诊疗的可行性。
3) Cancer/testis antigen
癌/睾丸抗原
1.
Cancer/testis antigen(CTA) genes are specifically expressed in the normal testis and various types of cancer cells,while not or expressed with very low level in other normal tissues.
癌/睾丸抗原(Cancer/Testis Antigen,CTA)基因在正常睾丸组织的生殖细胞和多种不同组织类型的癌细胞中特异表达,在其它正常组织不表达或表达水平较低,并且在癌症患者中有抗原性免疫反应,认为是一类理想的肿瘤疫苗靶分子。
4) cancer testis antigen
癌-睾丸抗原
1.
OBJECTIVE: The purpose of this study was to determine the potential of three cancer testis antigens (CTA) as vaccines for human meningioma.
目的：探讨三种癌-睾丸抗原用于脑膜瘤免疫治疗的可能性。
6) adenocarcinoma of testis
睾丸腺癌
补充资料：原位癌
原位癌
上皮层的细胞发生癌变，但尚未穿透基底膜而浸润周围结缔组织，故又称"上皮内癌"。为癌瘤的最早阶段，一般没有明显症状，多在普查中或手术后经病理诊断发现。原位癌经手术治疗后一般可获痊愈。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条